Listed

Ernexa Therapeutics Inc.: Form 10-K for the period ended Dec 31, 2014

Filed with the SEC on Mar 27, 2015 and accepted by EDGAR at Mar 27, 2015, 14:29 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2014-12-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue12 months2014-01-01 to 2014-12-31$26.0mus-gaap:Revenues
Selling, general and administrative12 months2014-01-01 to 2014-12-31$18.4mus-gaap:SellingGeneralAndAdministrativeExpense
Operating income12 months2014-01-01 to 2014-12-31−$4.7mus-gaap:OperatingIncomeLoss
Interest expense12 months2014-01-01 to 2014-12-31$223.0kus-gaap:InterestExpense
Income tax12 months2014-01-01 to 2014-12-31$84.0kus-gaap:IncomeTaxExpenseBenefit
Net income12 months2014-01-01 to 2014-12-31−$5.0mus-gaap:NetIncomeLoss
Diluted EPS12 months2014-01-01 to 2014-12-31−$0.06us-gaap:EarningsPerShareBasicAndDiluted
Operating cash flow12 months2014-01-01 to 2014-12-31−$6.4mus-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
Capital expenditure12 months2014-01-01 to 2014-12-31$835.0kus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Cash and equivalentsAt period end2014-12-31$7.2mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2014-12-31$14.9mus-gaap:AssetsCurrent
Total assetsAt period end2014-12-31$22.3mus-gaap:Assets
Current liabilitiesAt period end2014-12-31$7.1mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2014-12-31$11.3mus-gaap:Liabilities
Long-term debtAt period end2014-12-31$5.3mus-gaap:LongTermDebt
Current portion of debtAt period end2014-12-31$2.2mus-gaap:LongTermDebtCurrent
Shareholders' equityAt period end2014-12-31$10.9mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001019687-15-001115. Last ingested by Listed: Nov 11, 2026, 02:49 ET. Listed shows no prices and gives no investment advice.